Bone Marrow, Cytokines, and Bone Remodeling-Emerging Insights into the Pathophysiology of Osteoporosis

New England Journal of Medicine

Volumn 332, Issue 5, 1995, Pages 305-311

  Manolagas, Stavros C ^a   Jilka, Robert L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; COLECALCIFEROL; COLONY STIMULATING FACTOR 1; ESTROGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 6;

ANIMAL; BONE MARROW; BONE REMODELING; FEMALE; HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; GONAD DYSFUNCTION; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; SENESCENCE;

ANIMAL; BONE MARROW; BONE REMODELING; CYTOKINES; FEMALE; HUMAN; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028925088     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199502023320506     Document Type: Review

References (63)

1. Parfitt AM Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994; 55: 273-286
2. Parfitt AM The two-stage concept of bone loss revisited. Triangle 1992; 31: 99-110
3. Shevde N, Anklesaria P, Greenberger JS, Bleiberg I, Glowacki J Stromal cell-mediated stimulation of osteoclastogenesis. Proc Soc Exp Biol Med 1994; 205: 306-315
4. Suda T, Takahashi N, Martin TJ Modulation of osteoclast differentiation. Endocr Rev 1992; 13: 66-80
5. Owen M. Lineage of osteogenic cells and their relationship to the stromal system. In: Peck WA, ed. Bone and mineral research/3. Amsterdam: Elsevier, 1985:1-25.
6. Malaval L, Modrowski D, Gupta AK, Aubin JE Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 1994; 158: 555-572
7. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Rel Res 1980; 151: 294-307
8. Benayahu D, Kletter Y, Zipori D, Wientroub S Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J Cell Physiol 1989; 140: 1-7
9. Benayahu D, Fried A, Zipori D, Wientroub S Subpopulations of marrow stromal cells share a variety of osteoblastic markers. Calcif Tissue Int 1991; 49: 202-207
10. Mundy GR. Local factors regulating osteoclast function. In: Rifkin BR, Gay CV, eds. Biology and physiology of the osteoclast. Boca Raton, Fla.: CRC Press, 1992:171-85.
11. Horowitz MC, Jilka RL. Colony stimulating factors and bone remodeling. In: Gowen M, ed. Cytokines and bone metabolism. Boca Raton, Fla.: CRC Press, 1992:185-227.
12. Girasole G, Passeri G, Jilka RL, Manolagas SC Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994; 93: 1516-1524
13. Taichman RS, Emerson SG Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994; 179: 1677-1682
14. Kurihara N, Chenu C, Miller M, Civin C, Roodman GD Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 1990; 126: 2733-2741
15. Hattersley G, Kerby JA, Chambers TJ Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology 1991; 128: 259-262
16. Marks SC Jr, Walker DG. Mammalian osteopetrosis — a model for studying cellular and humoral factors in bone resorption. In: Bourne GH, ed. The biochemistry and physiology of bone. 2nd ed. Vol. 4. New York: Academic Press, 1976:227-301.
17. Serke S, Sauberlich S, Abe Y, Huhn D Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays. Ann Hematol 1991; 62: 45-53
18. Demulder A, Suggs SV, Zsebo KM, Scarcez T, Roodman GD Effects of stem cell factor on osteoclast-like cell formation in long-term human marrow cultures. J Bone Miner Res 1992; 7: 1337-1344
19. Kurihara N, Civin C, Roodman GD Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 1991; 6: 257-261
20. Ishimi Y, Miyaura C, Jin CH, IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297-3303
21. Lowik CW, van der Pluijm G, Bloys H, Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989; 162: 1546-1552
22. Black K, Garrett IR, Mundy GR Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 1991; 128: 2657-2659
23. al-Humidan A, Ralston SH, Hughes DE, Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J Bone Miner Res 1991; 6: 3-8
24. Tamura T, Udagawa N, Takahashi N, Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 1993; 90: 11924-11928
25. Manolagas SC, Jilka RL, Girasole G, Passeri G, Bellido T. Estrogens, cytokines, and the pathophysiology of osteoporosis. In: Kohler PO, ed. Current opinion in endocrinology and diabetes. Philadelphia: Current Science, 1994:275-81.
26. Ohsaki Y, Takahashi S, Scarcez T, Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology 1992; 131: 2229-2234
27. Klein B, Wijdenes J, Zhang X-G, Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991; 78: 1198-1204
28. Roodman GD, Kurihara N, Ohsaki Y, Interleukin 6: a potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 1992; 89: 46-52
29. Kotake S, Sato K, Kim KJ, Interleukin-6 and soluble interleukin-6 receptors found in synovial fluids are responsible for inducing joint disruption in patients with rheumatoid arthritis. J Bone Miner Res 1994; 9: Suppl 1: S140-S140 abstract.
30. Devlin RD, Bone HG III, Roodman GD Stimulation of osteoclast-like multinucleated cell (MNC) formation in long-term human bone marrow culture by the serum of patients with Gorham-Stout or disappearing bone disease. J Bone Miner Res 1994; 9: Suppl 1: S140-S140 abstract.
31. Dempster DW, Shane E, Horbert W, Lindsay R A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects. J Bone Miner Res 1986; 1: 15-21
32. Gallagher JC, Goldgar D, Moy A Total bone calcium in normal women: effect of age and menopause status. J Bone Miner Res 1987; 2: 491-496
33. Heaney RP Estrogen-calcium interactions in the postmenopause: a quantitative description. Bone Miner 1990; 11: 67-84
34. Nordin BE, Need AG, Bridges A, Horowitz M Relative contributions of years since menopause, age, and weight to vertebral density in postmenopausal women. J Clin Endocrinol Metab 1992; 74: 20-23
35. Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 1988; 67: 741-748
36. Balena R, Toolan BC, Shea M, The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 1993; 92: 2577-2586
37. Poli V, Balena R, Fattori E, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13: 1189-1196
38. Kalu DN The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991; 15: 175-191
39. Turner RT, Wakley GK, Hannon KS, Bell NH Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology 1988; 122: 1146-1150
40. Parfitt AM. Bone-forming cells in clinical conditions. In: Hall BK, ed. The osteoblast and osteocyte. Vol. 1 of Bone. Boca Raton, Fla.: Telford Press/ CRC Press, 1990:351-429.
41. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL Cancellous bone remodeling in type 1 (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 1990; 5: 311-319
42. Girasole G, Jilka RL, Passeri G, 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992; 89: 883-891
43. Chaudhary LR, Spelsberg TC, Riggs BL Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: lack of regulation by 17β-estradiol. Endocrinology 1992; 130: 2528-2534
44. Pottratz S, Bellido T, Mocharla H, Crabb D, Manolagas SC 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994; 93: 944-950
45. Ray A, Prefontaine KE, Ray P Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994; 269: 12940-12946
46. Bellido T, Girasole G, Jilka RL, Crabb D, Manolagas SC Demonstration of androgen receptors in bone marrow stromal cells and their role in the regulation of transcription from the human interleukin-6 (IL-6) gene promoter. J Bone Miner Res 1993; 8: Suppl 1: S131-S131 abstract.
47. Jilka RL, Hangoc G, Girasole G, Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88-91
48. Passeri G, Girasole G, Jilka RL, Manolagas SC Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 1993; 133: 822-828
49. Bismar H, Diel I, Ziegler R, Pfeilschifter J Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Bone Miner Res 1994; 9: Suppl 1: S158-S158 abstract.
50. Jilka RL, Girasole G, Passeri G, Munshi M, Howe N, Manolagas SC Estrogen deficiency induces sensitivity of the osteoclastogenic process to IL-6. J Bone Miner Res 1994; 9: Suppl 1: S143-S143 abstract.
51. Girasole G, Passeri G, Knutson S, Manolagas SC, Jilka RL Upregulation of osteoclastogenic potential of the marrow is induced by orchidectomy and is reversed by testosterone replacement in the mouse. J Bone Miner Res 1992; 7: Suppl 1: S96-S96 abstract.
52. Kimble RB, Vannice JL, Bloedow DC, Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994; 93: 1959-1967
53. Jilka RL, Williams D, Manolagas SC Ovariectomy in mice increases osteocalcin levels in the serum and enhances osteoblast progenitor formation in the bone marrow. Bone Miner 1994; 25: S15-S15 abstract.
54. Evans DB, Gerber B, Feyen JH Recombinant human leukemia inhibitory factor is mitogenic for human bone-derived osteoblast-like cells. Biochem Biophys Res Commun 1994; 199: 220-226
55. Rodan SB, Wesolowski G, Hilton DJ, Nicola NA, Rodan GA Leukemia inhibitory factor binds with high affinity to preosteoblastic RCT-1 cells and potentiates the retinoic acid induction of alkaline phosphatase. Endocrinology 1990; 127: 1602-1608
56. Metcalf D, Gearing DP Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci U S A 1989; 86: 5948-5952
57. Kishimoto T, Taga T, Akira S Cytokine signal transduction. Cell 1994; 76: 253-262
58. Stahl N, Yancopoulos GD The alphas, betas, and kinases of cytokine receptor complexes. Cell 1993; 74: 587-590
59. Bellido T, Girasole G, Passeri G, Jilka RL, Manolagas SC Sex steroids regulate the expression of the gp130 transduction pathway by bone marrow and bone cells. Bone Miner 1994; 25: S39-S39 abstract.
60. Matsushita M, Tsuboyama T, Kasai R, Age-related changes in bone mass in the senescence-accelerated mouse (SAM): SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol 1986; 125: 276-283
61. Manolagas SC, Knutson S, Jilka RL The senescence accelerated mouse (SAM-P/6), a model of senile osteoporosis, exhibits decreased osteoclastogenesis and fails to upregulate this process following ovariectomy. J Bone Miner Res 1993; 8: Suppl 1: S141-S141 abstract.
62. Sato T, Miyama K, Tamura M, Katagiri T, Suda T Characterization of osteoblastic cells and bone marrow cells obtained from congenitally osteoporotic SAM-P/6 mice. J Bone Miner Res 1992; 7: Suppl 1: S272-S272 abstract.
63. Arlot M, Edouard C, Meunier PJ, Neer RM, Reeve J Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry. BMJ 1984; 289: 517-520